Holen Sie sich die Stockscreener-App
16.68
0.60%
-0.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Baxter International Inc Aktie (BAX) Neueste Nachrichten
How Investors May Respond To Baxter International (BAX) Expanding Into Automated IV Line Labeling Systems - Yahoo Finance
Does Baxter’s New IV Verify Labeling System Redefine Its Automation Edge In Healthcare Workflow Efficiency (BAX)? - simplywall.st
BAXTER INTERNATIONAL INC. R (BTL.HM) Q2 FY2025 earnings call transcript - Yahoo Finance
Baxter International unveils IV Verify to enhance IV labeling accuracy - MSN
Columbia Intrinsic Value Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter’s IV Verify Launch Tests Medication Safety Strategy And Hospital Traction - simplywall.st
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International Introduces IV Verify to Improve the Precision of IV Labeling - Bitget
Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy - Yahoo Finance
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings - BioSpace
Pet Partners, Baxter Foundation Expand Therapy Animal Programs for Patients, Healthcare Workers - Pet Age
Baxter (BAX) Unveils New IV Verify Line Labeling System for Nurs - GuruFocus
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter International Hits New 52-Week Low at $15.87 - Markets Mojo
Baxter International Inc (BAX) Stock Price Down 4.2% on Mar 30 - GuruFocus
Baxter launches IV labeling system aimed at improving safety, efficiency - Medical Economics
Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot - Bioscience Association Manitoba
Baxter debuts automated IV line labeling system By Investing.com - in.investing.com
Baxter debuts automated IV line labeling system - Investing.com
Baxter stock price forecast: bearish trend persists as BAX trades near 52-week lows - Traders Union
Baxter Foundation Therapy Animal Push And What It Means For Investors - simplywall.st
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International (NYSE:BAX) Hits New 1-Year LowTime to Sell? - MarketBeat
Baxter International stock hits 52-week low at 16.07 USD By Investing.com - Investing.com Australia
Baxter International stock hits 52-week low at 16.07 USD - Investing.com
BAX SEC FilingsBaxter Intl Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Clinical Nutrition for Cancer Care: 2026-2030 Market - GlobeNewswire
Clinical Nutrition for Cancer Care: 2026-2030 Market Analysis Featuring Profiles of Leading PlayersAbbott Nutrition, Baxter International, B Braun Melsungen, Nestle Health Science, Danone Nutricia and More - Yahoo Finance UK
Bank of America maintains a hold rating on Baxter International (BAX) - MSN
Baxter International Stock: Navigating Leadership Changes and Portfolio Optimization Amid Market Pre - AD HOC NEWS
Bank of America Maintains a Hold Rating on Baxter International (BAX) - Insider Monkey
A Look At Baxter International (BAX) Valuation As CFO Transition Draws Investor Attention - simplywall.st
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
[SCHEDULE 13G/A] BAXTER INTERNATIONAL INC Amended Passive Investment Disclosure - Stock Titan
SG Americas Securities LLC Has $32.97 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Baxter to Host Annual Meeting of Stockholders in Virtual Format - marketscreener.com
Baxter investors get online-only annual meeting, with voting on May 5 - Stock Titan
Baxter International stock faces pressure from ifosfamide shortage and reduced production capacity a - AD HOC NEWS
Manufacturing Disruption Hits Baxter Cancer Drug Supply In Europe - sahmcapital.com
Therapy animals will reach 100,000 patients and care teams in pilot - Stock Titan
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks - Benzinga
Revenue of Baxter International from 2021 to 2025 - Statista
EU regulator flags Baxter cancer drug shortage until early next year - KELO-AM
Baxter International Stock Hits Day Low of $16.08 Amid Price Pressure - Markets Mojo
Baxter International Inc. stock faces pressure from EU cancer drug shortage warning until early 2027 - AD HOC NEWS
Baxter says production of ifosfamide resumed, but at reduced capacity that does not meet current demand - marketscreener.com
The Bull Case For Baxter International (BAX) Could Change Following CFO Turnover And FTSE Index Removal - simplywall.st
EU regulator warns of shortage in Baxter's cancer treatment until early 2027 - marketscreener.com
Baxter International Opens Weak with 6.19% Gap Down Amid Market Concerns - Markets Mojo
Baxter International Hits New 52-Week Low at $16.08 - Markets Mojo
Baxter International : 2025 Proxy Statement - marketscreener.com
BAXTER INTERNATIONAL INC ($BAX) Former Chair of the Board, President and CEO 2025 Pay Revealed - quiverquant.com
Baxter International's GC Earned $3.8M In 2025 - Law360
Baxter International Inc stock faces renewed pressure amid kidney care challenges and acquisition in - AD HOC NEWS
Baxter (NYSE: BAX) sets 2026 votes on pay, board size and incentive plan - Stock Titan
1.21%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):